Detailed answers about PATIENT-CENTRED OUTCOMES ASSESSMENTS LTD., including incorporation, status, business activity, and accounts information.
When was PATIENT-CENTRED OUTCOMES ASSESSMENTS LTD. founded?
PATIENT-CENTRED OUTCOMES ASSESSMENTS LTD. was officially incorporated on 11 July 2013 and is registered under company number 08606091. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is PATIENT-CENTRED OUTCOMES ASSESSMENTS LTD.?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of PATIENT-CENTRED OUTCOMES ASSESSMENTS LTD.?
PATIENT-CENTRED OUTCOMES ASSESSMENTS LTD.'s current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does PATIENT-CENTRED OUTCOMES ASSESSMENTS LTD. do?
PATIENT-CENTRED OUTCOMES ASSESSMENTS LTD. operates in the following sector: 70229 - Management consultancy activities other than financial management. This provides insight into the company's primary business activity and industry focus.
What is PATIENT-CENTRED OUTCOMES ASSESSMENTS LTD.'s registered address?
The registered office address of PATIENT-CENTRED OUTCOMES ASSESSMENTS LTD. is C/O LINDA ABETZ-WEBB, 1 SPRINGBANK, BOLLINGTON, MACCLESFIELD, CHESHIRE, SK10 5LQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is PATIENT-CENTRED OUTCOMES ASSESSMENTS LTD. financially stable?
The most recent accounts for PATIENT-CENTRED OUTCOMES ASSESSMENTS LTD. were made up to 31 July 2024, filed as MICRO ENTITY. Next accounts are due by 30 April 2026.